A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets

Clinical trial NCT06165822 · UNKNOWN

Trial details

NCT number: NCT06165822
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Neoplasm

Start date: 2023-12-01
Primary completion: 2024-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.